These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1098 related articles for article (PubMed ID: 34058196)
1. Role of host factors in SARS-CoV-2 entry. Evans JP; Liu SL J Biol Chem; 2021 Jul; 297(1):100847. PubMed ID: 34058196 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2. Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T Cells; 2021 Jun; 10(6):. PubMed ID: 34201214 [TBL] [Abstract][Full Text] [Related]
3. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786 [TBL] [Abstract][Full Text] [Related]
4. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy. Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788 [TBL] [Abstract][Full Text] [Related]
5. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review). Katopodis P; Randeva HS; Spandidos DA; Saravi S; Kyrou I; Karteris E Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935057 [TBL] [Abstract][Full Text] [Related]
6. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. Muralidar S; Gopal G; Visaga Ambi S J Med Virol; 2021 Sep; 93(9):5260-5276. PubMed ID: 33851732 [TBL] [Abstract][Full Text] [Related]
7. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466 [TBL] [Abstract][Full Text] [Related]
8. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Wei C; Wan L; Yan Q; Wang X; Zhang J; Yang X; Zhang Y; Fan C; Li D; Deng Y; Sun J; Gong J; Yang X; Wang Y; Wang X; Li J; Yang H; Li H; Zhang Z; Wang R; Du P; Zong Y; Yin F; Zhang W; Wang N; Peng Y; Lin H; Feng J; Qin C; Chen W; Gao Q; Zhang R; Cao Y; Zhong H Nat Metab; 2020 Dec; 2(12):1391-1400. PubMed ID: 33244168 [TBL] [Abstract][Full Text] [Related]
9. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor. Shilts J; Crozier TWM; Greenwood EJD; Lehner PJ; Wright GJ Sci Rep; 2021 Jan; 11(1):413. PubMed ID: 33432067 [TBL] [Abstract][Full Text] [Related]
10. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2. Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482 [TBL] [Abstract][Full Text] [Related]
11. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection. Fuentes-Prior P J Biol Chem; 2021; 296():100135. PubMed ID: 33268377 [TBL] [Abstract][Full Text] [Related]
12. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes. Guney C; Akar F J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315 [TBL] [Abstract][Full Text] [Related]
13. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. Koch J; Uckeley ZM; Doldan P; Stanifer M; Boulant S; Lozach PY EMBO J; 2021 Aug; 40(16):e107821. PubMed ID: 34159616 [TBL] [Abstract][Full Text] [Related]
14. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V. Bollavaram K; Leeman TH; Lee MW; Kulkarni A; Upshaw SG; Yang J; Song H; Platt MO Protein Sci; 2021 Jun; 30(6):1131-1143. PubMed ID: 33786919 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction. Kim CH Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730 [TBL] [Abstract][Full Text] [Related]
16. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2. Hudák A; Letoha A; Szilák L; Letoha T Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069441 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry. Ren W; Zhu Y; Wang Y; Shi H; Yu Y; Hu G; Feng F; Zhao X; Lan J; Wu J; Kenney DJ; Douam F; Tong Y; Zhong J; Xie Y; Wang X; Yuan Z; Zhou D; Zhang R; Ding Q PLoS Pathog; 2021 Mar; 17(3):e1009392. PubMed ID: 33760889 [TBL] [Abstract][Full Text] [Related]
18. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies. Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936 [TBL] [Abstract][Full Text] [Related]
19. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein. Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076 [TBL] [Abstract][Full Text] [Related]
20. Effects of endurance training on the expression of host proteins involved in SARS-CoV-2 cell entry in C57BL/6J mouse. Tamura Y; Jee E; Kouzaki K; Kotani T; Nakazato K Physiol Rep; 2021 Sep; 9(17):e15014. PubMed ID: 34523264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]